{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:44:00Z","timestamp":1780091040201,"version":"3.54.0"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,9]]},"DOI":"10.18632\/oncotarget.23661","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T10:25:09Z","timestamp":1514283909000},"page":"4044-4060","source":"Crossref","is-referenced-by-count":13,"title":["Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cells"],"prefix":"10.18632","volume":"9","author":[{"given":"Melissa","family":"Hodeib","sequence":"first","affiliation":[{"name":"Women\u2019s Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Ogrodzinski","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA"},{"name":"Department of Physiology, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Vergnes","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Reue","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[{"name":"Women\u2019s Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia Y.","family":"Lunt","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Joseph P.","family":"Aspuria","sequence":"additional","affiliation":[{"name":"Women\u2019s Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Martins","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.fertnstert.2008.04.073","article-title":"Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective","volume":"90","author":"Nestler","year":"2008","journal-title":"Fertil Steril"},{"key":"4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Morris","year":"2005","journal-title":"BMJ"},{"key":"5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/ijc.29944","article-title":"Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: results from the women\u2019s health initiative","volume":"138","author":"Luo","year":"2016","journal-title":"Int J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","article-title":"LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin","volume":"23","author":"Shaw","year":"2013","journal-title":"Cancer Cell"},{"key":"7","doi-asserted-by":"publisher","first-page":"10574","DOI":"10.1073\/pnas.1409844111","article-title":"Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and ntps in cancer stem cells","volume":"111","author":"Struhl","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ygyno.2012.07.115","article-title":"Metformin targets ovarian cancer stem cellsand","volume":"127","author":"Buckanovich","year":"2012","journal-title":"Gynecol Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Sakamoto","year":"2013","journal-title":"Diabetologia"},{"key":"10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Korbonits","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"11","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex i of cancer cells to reduce tumorigenesis","volume":"3","author":"Chandel","year":"2014","journal-title":"Elife"},{"key":"12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","article-title":"Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers","volume":"24","author":"Locasale","year":"2016","journal-title":"Cell Metab"},{"key":"13","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, independent of ampk, induces mTOR inhibition and cell-cycle arrest through REDD1","volume":"71","author":"Bost","year":"2011","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"27692","DOI":"10.1074\/jbc.M114.592576","article-title":"Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors","volume":"289","author":"Safe","year":"2014","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cmet.2016.09.006","article-title":"Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin","volume":"24","author":"Vander Heiden","year":"2016","journal-title":"Cell Metab"},{"key":"16","doi-asserted-by":"publisher","first-page":"23548","DOI":"10.18632\/oncotarget.4556","article-title":"Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer","volume":"6","author":"Romero","year":"2015","journal-title":"Oncotarget"},{"key":"17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ygyno.2014.10.011","article-title":"Old drug, new trick: repurposing metformin for gynecologic cancers?","volume":"135","author":"Romero","year":"2014","journal-title":"Gynecol Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Schultz","year":"2013","journal-title":"Nat Commun"},{"key":"19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It\u2019s totally tubular....Riding the new wave of ovarian cancer research","volume":"76","author":"Drapkin","year":"2016","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"e80314","DOI":"10.1371\/journal.pone.0080314","article-title":"Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes","volume":"8","author":"Jones","year":"2013","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2049-3002-2-12","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"2","author":"St-Pierre","year":"2014","journal-title":"Cancer Metab"},{"key":"22","doi-asserted-by":"publisher","first-page":"e1002309","DOI":"10.1371\/journal.pbio.1002309","article-title":"Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis","volume":"13","author":"Jones","year":"2015","journal-title":"PLoS Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"E435","DOI":"10.1073\/pnas.1311121111","article-title":"Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK","volume":"111","author":"Kendler","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2015.181","article-title":"Protein acetylation in metabolism - metabolites and cofactors","volume":"12","author":"Auwerx","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.18632\/oncotarget.2673","article-title":"Cyclin E1 and RTK\/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS","volume":"6","author":"Walsh","year":"2015","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2049-3002-2-21","article-title":"Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism","volume":"2","author":"Orsulic","year":"2014","journal-title":"Cancer Metab"},{"key":"28","volume-title":"current protocols in bioinformatics","author":"Rabinowitz","year":"2012"},{"key":"29","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1021\/ac1021166","article-title":"Metabolomic analysis and visualization engine for LC\u2212MS data","volume":"82","author":"Rabinowitz","year":"2010","journal-title":"Anal Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:07:48Z","timestamp":1589022468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,23]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,1,9]]}},"alternative-id":["23661","29423103"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23661","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,23]]}}}